Overview

Taste Evaluation of Different Liquid Formulations With Eliglustat

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
Primary Objective: The purpose of this study is to assess the palatability of eliglustat prototype liquid formulations in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Genzyme, a Sanofi Company
Treatments:
Eliglustat